ARTICLE | Company News
BioFocus, Australian Cancer Technologies deal
July 16, 2001 7:00 AM UTC
BIO and Australian Cancer will develop small molecule tyrosine kinase receptor modulators for use in treating breast cancer. BIO will contribute its Retroviral Display assay system to detect cell surf...